ATG5 and cancer: Interestingly, in a breast cancer model it was shown that Lamp2A down-regulation induces ATG5 protein levels increase and inhibited cancer cell growth and metastasis (34), suggesting that an inhibition of CMA activity could be an option to reverse the malignant phenotype dependent on ATG5 protein alterations.